SCHEMBL5347416

SCHEMBL5347416

Nc1ccc2nc(C3CC3)ccc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLAU P00749 1/20 0.55
▸ KDM4E B2RXH2 4/20 0.52
▸ LMNA P02545 2/20 0.52
▸ POLB P06746 1/20 0.52
▸ CASP6 P55212 1/20 0.52
▸ KCNH2 Q12809 2/20 0.45
▸ HRH3 Q9Y5N1 2/20 0.45
▸ HTT P42858 2/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ F2 P00734 1/20 0.45
▸ CHRM2 P08172 1/20 0.45
▸ HTR1A P08908 1/20 0.45
▸ ADRA2A P08913 1/20 0.45
▸ ADORA3 P0DMS8 1/20 0.45
▸ MAOA P21397 1/20 0.45
▸ DRD1 P21728 1/20 0.45
▸ ACHE P22303 1/20 0.45
▸ PTGS1 P23219 1/20 0.45
▸ SLC6A2 P23975 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30718832 0.78 BACE1 (0.52) KDM4EPOLBKCNH2HRH3HTT
SCHEMBL27150635 0.78 BACE1 (0.52) KDM4EPOLBKCNH2HRH3HTT
SCHEMBL21416784 0.78 KCNH2 (0.44) POLBKCNH2HRH3BACE1IDO1
SCHEMBL4816102 0.75 POLB (0.43) PLAUKDM4EPOLBMEN1KMT2A
SCHEMBL3858510 0.75 PLAU (0.44) PLAUKDM4ELMNAPOLBCASP6
SCHEMBL6852521 0.75 PLAU (0.44) PLAUKDM4ELMNAPOLBCASP6
SCHEMBL23062649 0.74 NCF1 (0.35) KCNH2HRH3ACHEMAPTBACE1
SCHEMBL27152277 0.74 KCNH2 (0.41) KDM4EPOLBKCNH2HRH3MEN1
SCHEMBL1644720 0.73 POLB (0.48) KDM4EPOLBKCNH2HRH3MEN1
SCHEMBL29390450 0.72 NPC1 (0.52) KDM4EPOLBHRH3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7189714-B2 N-type calcium channel antagonists for the treatment of pain ASTRAZENECA AB (SE) 2007-03-13 — — US disclosed
Send feedback